Showing results (21-30 of 379) with videos related to
Sort By:
Pageof 38
Life (Basel, Switzerland)|December 24, 2021
Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced MelanomaDevayani Machiraju, Sarah Schäfer, Jessica C HasselCancers|October 14, 2022
Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous RituximabChristian Menzer, Adriana Rendon, Jessica C HasselEuropean Journal of Cancer (Oxford, England : 1990)|March 13, 2024
The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrationsKatrin Schaper-Gerhardt, Ralf Gutzmer, Yenny Angela, et al.Clinical Nuclear Medicine|November 7, 2015
18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With PembrolizumabChristos Sachpekidis, Jessica C Hassel, Antonia Dimitrakopoulou-StraussAmerican Journal of Clinical Dermatology|December 20, 2024
Prognostic Biomarkers in Evolving Melanoma ImmunotherapyRobin Reschke, Alexander H Enk, Jessica C HasselInternational Journal of Molecular Sciences|June 27, 2024
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic TargetsRobin Reschke, Alexander H Enk, Jessica C HasselHellenic Journal of Nuclear Medicine|November 28, 2017
Metastatic melanoma response to combination therapy with ipilimumab and vemurafenibChristos Sachpekidis, Jessica C Hassel, Antonia Dimitrakopoulou-StraussDermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 25, 2010
Phenol chemical matricectomy is less painful, with shorter recovery times but higher recurrence rates, than surgical matricectomy: a patient's viewJessica C Hassel, Alexander J Hassel, Christoph LöserCancers|March 10, 2022
TCR-Directed Therapy in the Treatment of Metastatic Uveal MelanomaSophia B Strobel, Devayani Machiraju, Jessica C HasselPharmaceutics|August 29, 2024
T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous MelanomaRobin Reschke, Alexander H Enk, Jessica C HasselPageof 38